Mehr lesen
This book provides an in-depth explanation of the advantages and current limitations of recombinant plant-made vaccines for use in veterinary medicine, including for livestock, pets, and wild animals. Written by top scientists in the field, it discusses the background to and latest scientific advances in plant-made vaccines for the most commonly targeted veterinary infections.
With the recent high-profile research into recombinant plant-made therapeutics for Ebola and Zika viruses, it is likely that the products will be commercialized and widely used in the future. Plant-made therapeutics have a variety of advantages over those made in traditional systems; however, their most fruitful application may be in veterinary medicine, due to less stringent regulations and a greater need for low-cost products.
Inhaltsverzeichnis
1) History and promise of plant-made vaccines for animals, Ed Rybicki.- 2) Plant transformation strategies, Verónica Araceli Márquez-Escobar, Omar González-Ortega, Sergio Rosales-Mendoza.- Vaccines for wild, feral and companion animals , 3) Rabies and related lyssaviruses, Charles E. Rupprecht, Rachel Chikwamba.- 4) A comprehensive review of Toxoplasma gondii biology and host-cell interaction: challenges for a plant-based vaccine, Valeria Sander, Sergio O. Angel, Marina Clemente.- 5) Vaccines against West Nile virus, Haiyan Sun, Qiang Chen.- Vaccines for poultry, 6) Plant-made veterinary vaccines for Newcastle disease virus, David R. Thomas, Amanda M. Walmsley.- 7) Infectious bursal disease virus, Evangelina Gómez, Soledad Lucero, Matías Richetta, Silvina Chimeno Zoth, Analía Berinstein.- 8) Plant-produced avian influenza antigens, Yanaysi Ceballo, Alina Lopez, Kenia Tiel, Abel Hernandez.- 9) Plant-made vaccines against avian reovirus, Ching-Chun Chang, Hung-Jen Liu.- Vaccines for swine, 10) Toward the optimization of a plant-based oral vaccine against cysticercosis, Edda Sciutto, Marisela Hernández, Jacquelynne Cervantes-Torres, Elizabeth Monreal - Escalante, Omayra Bolaños-Martínez, Juan Francisco Rodríguez, Gladis Fragoso, Sergio, Rosales-Mendoza.- 11) Classical swine fever virus, Han Sang Yoo.- 12) Porcine epidemic diarrhea virus, Zayn Khamis, Rima Menassa.- 13) Porcine reproductive and respiratory syndrome (PRRS), Elizabeth Loza-Rubio, Edith Rojas-Anaya.- Vaccines for ruminants, 14) The benefit of a plant-based cattle vaccine for reducing Enterohemorrhagic Escherichia coli shedding and improving food safety, Adam Chin-Fatt, Ed Topp, Rima Menassa.- 15) Foot-and-mouth disease, Vanesa Ruiz, Andrés Wigdorovitz.- Vaccines with limited research, 16) Diseases with limited research of plant-based vaccines, Ann Meyers.
Über den Autor / die Autorin
Jacqueline MacDonald earned a PhD in the Department of Chemical Engineering at the University of Toronto. With a strong background in molecular biology, she has worked with plants, animals, fungi, and bacteria, mostly with biotechnological applications. Her postdoctoral work involved plant-produced vaccine candidates for livestock with the goal of reducing the environmental and public health effects of antibiotics. Jacqueline currently teaches biotechnology, environmental sustainability, and health sciences at both Western University and Fanshawe College in London, Ontario, Canada.
Zusammenfassung
This book provides an in-depth explanation of the advantages and current limitations of recombinant plant-made vaccines for use in veterinary medicine, including for livestock, pets, and wild animals. Written by top scientists in the field, it discusses the background to and latest scientific advances in plant-made vaccines for the most commonly targeted veterinary infections.
With the recent high-profile research into recombinant plant-made therapeutics for Ebola and Zika viruses, it is likely that the products will be commercialized and widely used in the future. Plant-made therapeutics have a variety of advantages over those made in traditional systems; however, their most fruitful application may be in veterinary medicine, due to less stringent regulations and a greater need for low-cost products.
